IBD Preventative Care Flashcards
(16 cards)
All adult patients w/ IBD should undergo annual vaccination against influenza
conditional, very low evidence
Those on immunosuppressive therapies and their household contacts should receive the non-live trivalent inactivated influenza vaccine, but not the live inhaled influenza vaccine
conditional, very low evidence
Adult patients w/ IBD receiving immunosuppressive therapy should receive pneumococcal vaccination w/ both the PCV13 and PPSV23
conditional, very low evidence
Adults w/ IBD over the age of 50 should consider vaccination against herpes zoster, including certain subgroups of immunosuppressed patients
strong, low evidence
Adults w/ IBD should be assessed for prior exposure to varicella and vaccinated if naive before initiation of immunosuppressive therapy when possible
conditional, very low evidence
Patient w/ IBD who are immunosuppressed and traveling to endemic areas for yellow fever should consult w/ a travel medicine or ID specialist prior to travel
conditional, very low evidence
Adolescents with IBD should receive meningococcal vaccination in accordance w/ routine vaccination recommendations
conditional, very low evidence
Household members of immunosuppressed patients can receive liver vaccines w/ certain precautions
conditional, very low evidence
Adults w/ IBD should receive age-appropriate vaccinations before initiation of immune suppression when possible
conditional, very low evidence
Vaccination against Tdap, HAV, HBV, and HPV should be administered as per Advisory Committee on Immunization Practice guidelines
conditional, very low evidence
Women w/ IBD on immunosuppressive therapy should undergo annual cervical cancer screening
conditional, very low evidence
Screening for depression and anxiety is recommended in patients w/ IBD
conditional, low evidence
Patients w/ IBD should undergo screening for melanoma independent of the use of biologic therapy
strong, low evidence
IBD patients on immunomodulators (6-MP or azathioprine) should undergo screening for NMSC while using these agents, particularly over the age of 50
strong, low evidence
Patients w/ conventional risk factors for abnormal bone mineral density w/ UC and CD should undergo screening for osteoporosis w/ BMD testing at the time of diagnosis and periodically after diagnosis
conditional, very low evidence
Patients w/ CD who smoke should be counseled to quit
strong, low evidence